Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
35.84
-0.27 (-0.76%)
Jul 23, 2026, 9:41 AM EDT - Market open
Neurogene Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Neurogene stock has a consensus rating of "Strong Buy" and an average price target of $81.71. The average 1-year stock price forecast is 128.02% higher than the current stock price, while the lowest is $46 (+28.37%) and the highest is $180 (+402.30%).
Price Target: $81.71 (+128.02%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Neurogene stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 9 | 9 | 9 | 9 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $65 | Buy | Maintains | $65 | +81.39% | Jul 11, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $46 | Buy | Maintains | $46 | +28.37% | Jul 6, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $69 | Buy | Maintains | $69 | +92.55% | Jun 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $180 | Buy | Maintains | $180 | +402.30% | Jun 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +95.34% | Jun 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.31
from -4.24
EPS Next Year
-5.46
from -5.31
EPS and Forward PE are based on non-GAAP adjusted numbers.